A SCOTTISH provider of data analysis software has signed a ten-year deal with one of the world’s best-known medical establishments – Great Ormond Street Hospital (GOSH).
Under the agreement Aridhia, which has bases in Glasgow’s Queen Elizabeth University hospital and central Edinburgh, will deliver the research and innovation component of Great Ormond Street Hospital NHS Foundation Trust’s digital transformation programme.
GOSH will adopt Aridhia’s cloud-based data analysis platform AnalytiXagility as its digital research environment to enable, accelerate and transform how it manages its research projects. This service will be integrated with the trust’s new electronic patient record system.
The system is designed to enhance the way researchers access and analyse data in a secure and consistent fashion, and will enable teams to quickly access and extract value from data sources to accelerate the process of turning pioneering research into clinical practice.
Chris Roche, Aridhia’s CEO, said: “Great Ormond Street Hospital is world-renowned and it is an honour to be given the opportunity to support such extraordinary researchers deliver ground-breaking research across multiple clinical domains.
“For Great Ormond Street to select AnalytiXagility after a rigorous 12-month procurement process is great endorsement of our vision to accelerate clinical research.
“The trust was seeking a secure, scalable research platform that would allow their teams to collaborate on analysis and deliver rapid, auditable and reproducible results. AnalytiXagility satisfies these requirements. We are very much looking forward to working with them on this next stage of their research journey.”
Aridhia’s cloud-based platform provides a secure, neutral and supportive environment to conduct research and helps facilitate collaboration around data collection, curation, and management. It also offers access to an advanced suite of analytical tools and technologies.
Dr Peter Steer, chief executive of Great Ormond Street Hospital for Children NHS Foundation Trust, added: “We look forward to working with Aridhia to develop an innovative platform which will transform the way we undertake and collaborate on research. This will allow us to bring more life-saving treatments to children with rare diseases in the UK and worldwide.”
Why are you making commenting on The National only available to subscribers?
We know there are thousands of National readers who want to debate, argue and go back and forth in the comments section of our stories. We’ve got the most informed readers in Scotland, asking each other the big questions about the future of our country.
Unfortunately, though, these important debates are being spoiled by a vocal minority of trolls who aren’t really interested in the issues, try to derail the conversations, register under fake names, and post vile abuse.
So that’s why we’ve decided to make the ability to comment only available to our paying subscribers. That way, all the trolls who post abuse on our website will have to pay if they want to join the debate – and risk a permanent ban from the account that they subscribe with.
The conversation will go back to what it should be about – people who care passionately about the issues, but disagree constructively on what we should do about them. Let’s get that debate started!
Callum Baird, Editor of The National
Comments: Our rules
We want our comments to be a lively and valuable part of our community - a place where readers can debate and engage with the most important local issues. The ability to comment on our stories is a privilege, not a right, however, and that privilege may be withdrawn if it is abused or misused.
Please report any comments that break our rules.
Read the rules here